Author

Samuel A. Turner

University of Cambridge

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 4 Evolutionary Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 5 Organism:human· 4 Approach:experimental assay· 3 Assay:bulk RNA-seq· 2 Approach:statistical model· 2 Research Focus:database / resource· 1 Organism:mouse· 1 Organism:non-human primate· 1

Frequent Co-Authors

Derek J. SmithiD· 4 shared Bryan Spencer· 2 shared Caroline KikawaiD· 2 shared Janet A. EnglundiD· 2 shared Jesse D. BloomiD· 2 shared John HuddlestoniD· 2 shared Kirsten LacombeiD· 2 shared Mars StoneiD· 2 shared

Activity by Year

2026-2026 · peak 5/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersMicrobiology

Derek J. SmithORCID

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Near real-time data on the human neutralizing antibody landscape to influenza virus in summer of 2026 shows antigenic advance of H3N2 subclade K region D mutants and H1N1 D.3.1.1 Sa mutants

Caroline Kikawa, Andrew Butler, John Huddleston, Samuel A. Turner, Heidi Peck, Janet A. Englund, Kirsten Lacombe, Michael Paul Busch, Marion C. Lanteri, Mars Stone, Bryan Spencer, Alexander L. Greninger, Derek J. Smith, Stephanie Wallace, Helen Siobhan Marshall, , Jesse D. Bloom

This study reports neutralization titers from 355 human sera against 148 influenza strains, showing reduced neutralization of new H3N2 and H1N1 variants.

bioRxiv · Sep 21, 2026 · PreprintMicrobiology

Antigenic characterization of SARS-CoV-2 variants BA.3.2.1 and BA.3.2.2 in three animal models

Samuel A. Turner, Joey Olivier, Madison L Ellis, Katharine A. Floyd, Lilin Lai, Suzanne M. Scheaffer, Ionsei Hastings, Tamarand L. Darling, Blake A. Miller, Charmy J Patel, Hannah E. Peck, Daryll A. Vanover, Philip J. Santangelo, Michael S. Diamond, Mehul S. Suthar, , Derek J. Smith

This study characterizes the antigenic properties of SARS-CoV-2 variants BA.3.2.1 and BA.3.2.2 in three animal models and finds they are antigenically divergent from existing variants with lower homologous serum titers.

bioRxiv · May 26, 2026 · PreprintMicrobiology

Predicting the antigenic evolution of seasonal influenza viruses using phylogenetic convergence

Samuel A. Turner, David J. Pattinson, Ron A. M. Fouchier, Derek J. Smith

This study predicts antigenic evolution in seasonal influenza viruses by analyzing phylogenetic convergence of HA substitutions near the receptor binding site.

bioRxiv · Apr 10, 2026 · PreprintEvolutionary Biology

Emergence and antigenic characterisation of influenza A(H3N2) viruses with hemagglutinin substitutions N158K and K189R during the 2024/25 influenza season

Björn F. Koel, Alexander Byrne, Samuel A. Turner, Sarah L. James, Ruth Harvey, Mónica Galiano, Christine Carr, Pascal Lexmond, Mark Pronk, Ruonan Liang, Geert‐Jan Boons, Robert P. de Vries, Dirk Eggink, Nicola S. Lewis, Derek Smith, , Ron A. M. Fouchier

This study characterizes the emergence and antigenic properties of influenza A(H3N2) viruses with N158K and K189R substitutions, showing they are antigenically distinct from vaccine strains and may reduce vaccine effectiveness.

bioRxiv · Feb 10, 2026 · PreprintMicrobiology

Near real-time data on the human neutralizing antibody landscape to influenza virus as of early 2026 to inform vaccine-strain selection

Caroline Kikawa, John Huddleston, Samuel A. Turner, Andrea N. Loes, Jiaojiao Liu, Sydney Gang, Tachianna Griffiths, Elizabeth M. Drapeau, Benjamin John Cowling, Faith C. S. Ho, Nancy Leung, Janet A. Englund, Kirsten Lacombe, Shinji Watanabe, Hideki Hasegawa, , Jesse D. Bloom

Sequencing-based neutralization of 91 H3N2 and H1N1 hemagglutinins against 302 human sera (27,409 titers) shows reduced titers to H3N2 subclade K and H1N1 D.3.1.1.

Virus Evolution · Jan 1, 2026Peer-reviewedMicrobiology✦ In-depth digest